OTCMKTS:KDRH

(KDRH) (KDRH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.20
$0.20
50-Day Range
N/A
52-Week Range
$0.00
$0.75
Volume
3,051 shs
Average Volume
47,180 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About (KDRH)

Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. It also invests in companies with technologies or medications focused on cannabinoid-based research. The company was founded in 1952 and is headquartered in Glendale, CO.

KDRH Stock News Headlines

BUY ALERT: Tiny tech play partners with US government
The Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).
BUY ALERT: Tiny tech play partners with US government
The Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).
Woman Has Genius Use for Thrifted Tie Rack
See More Headlines
Receive KDRH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (KDRH) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceuticals - Major
Sub-Industry
N/A
Current Symbol
OTCMKTS:KDRH
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Richard Greenberg
    Chairman & Chief Executive Officer
  • Robert I. Goldfarb
    Chief Operating Officer
  • Evan L. Wasoff
    CFO & Principal Accounting Officer
  • Jeremy Reeh
    VP-Translational Research
  • Frank Manganella
    Vice President-Corporate Development

This page (OTCMKTS:KDRH) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners